-
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?Blood tests that look for over a dozen cancers are being developed. But how soon will they help patients?
By RJ Mackenzie Published
-
It matters what time of day you get cancer treatment, study suggestsGiving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.
By Clarissa Brincat Published
-
Widespread cold virus you've never heard of may play key role in bladder cancerScientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a host immune system enzyme that attacks DNA.
By Jennifer Zieba Published
-
Science history: Female chemist initially barred from research helps develop drug for remarkable-but-short-lived recovery in children with leukemia — Dec. 6, 1954In December 1954, Gertrude Elion and colleagues described a new compound they had developed that sent children with leukemia into remission. It would guide a new approach to "rational drug design."
By Tia Ghose Published
12 Comments -
High-fiber diet may 'rejuvenate' immune cells that fight cancer, study findsA laboratory study reveals an interaction between dietary fiber and the gut microbiome that may be helpful for fighting cancer.
By RJ Mackenzie Published
3 Comments -
'Chemo brain' may stem from damage to the brain's drainage systemAn early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain. This is linked to memory issues in mice.
By Sophie Berdugo Published
-
COVID-19 mRNA vaccines can trigger the immune system to recognize and kill cancer, research findsThe researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
By Adam Grippin Published
6 Comments -
Could simple blood tests identify cancer earlier?Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?
By Emily Cooke Published
-
HPV vaccination drives cervical cancer rates down in both vaccinated and unvaccinated peopleResearchers have found that human papillomavirus (HPV) vaccines are highly effective at reducing cervical cancer-causing infections and can offer herd immunity, reinforcing previous research and highlighting the need for a global HPV vaccine rollout.
By Patrick Pester Published
2 Comments
